Clinical Evidence
Use of a Computer-Guided Glucose Management System to Improve Glycemic Control and Address National Quality Measures: A 7-Year, Retrospective Observational Study at a Tertiary Care Teaching Hospital
Objectives
This retrospective observational study evaluates the impact of using a computer-guided glucose management system (EndoTool) for patients admitted to intensive care and intermediate units, with an analysis of data from a period of seven years, 16,850 visits and 492,078 blood glucose readings.
Setting
900-bed tertiary care teaching hospital.
Results
- Average time to a target blood glucose <=180 mg/dL was between 1.5 and 2.3 hours.
- Average rate of glucose excursions (defined as a blood glucose >180 mg/dL after control was achieved) was 4%, at an average duration of 1.91 hours.
- Incidence of hypoglycemia <40 mg/dL was 0.03% of blood glucose readings.
- Incidence of hypoglycemia <70 mg/dL was 0.93% of blood glucose readings, a rate that decreased 96% over the study period, from 1.04% to 0.046%, concurrent to a near-doubling of visits.
- Among the subset of cardiovascular surgery patients, average time to a target blood glucose <140 mg/dL was between 4.5 and 4.8 hours and was achieved by ~98% of patients.
- Rate of hospital-acquired conditions per 1,000 under HAC-8 (manifestations of poor glycemic control) decreased 61%, from 0.083 pre-EndoTool to 0.032 post-EndoTool, for a ranking in the top 10% of U.S. hospitals.
Conclusions
Use of a computer-guided glucose management system (EndoTool) leads to significant improvements in overall glucose control and quality of care, with relatively rapid time to target, low rate of glucose excursions, minimal hypoglycemia and a marked decrease in the rate of hospital-acquired conditions under HAC-8 (manifestations of poor glycemic control).
References
Authors
Robert Tanenberg, MD, FACP; Sandra Hardee, PharmD, CDE; Caitlin Rothermel, MA, MPH; Almond Drake 3rd, MD, FACE.
Source
Published in Endocrine Practice, Volume 23, Issue 3, p331-341.
Year
2017
Related posts
Clinical Evidence
Achieving Optimal Glucose Control in Critical Care Units at Atrium Health
Achieving Optimal Glucose Control in Critical Care Units at Atrium Health
Clinical Evidence
Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings
Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings
Clinical Evidence
EndoTool IV Leads to Over 55% Fewer Blood Glucose Checks With an 84% Decrease in Hypoglycemic Events at UPMC
EndoTool IV Leads to Over 55% Fewer Blood Glucose Checks With an 84% Decrease in Hypoglycemic Events at UPMC
Get in Touch
Ready to get started?
"*" indicates required fields